Mycobacterium bovis BCG-Mediated Protection against W-Beijing Strains of Mycobacterium tuberculosis Is Diminished Concomitant with the Emergence of Regulatory T Cells

Despite issues relating to variable efficacy in the past, the Mycobacterium bovis BCG vaccine remains the basis for new-generation recombinant vaccines currently in clinical trials. To date, vaccines have been tested mostly against laboratory strains and not against the newly emerging clinical strai...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ordway, Diane J., Shang, Shaobin, Henao-Tamayo, Marcela, Obregon-Henao, Andres, Nold, Laura, Caraway, Megan, Shanley, Crystal A., Basaraba, Randall J., Duncan, Colleen G., Orme, Ian M.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2011
Предметы:
Vaccine Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165219/
https://ncbi.nlm.nih.gov/pubmed/21795460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.05127-11
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы